165 related articles for article (PubMed ID: 21508173)
1. Adjuvant activity of the catalytic A1 domain of cholera toxin for retroviral antigens delivered by GeneGun.
Bagley KC; Lewis GK; Fouts TR
Clin Vaccine Immunol; 2011 Jun; 18(6):922-30. PubMed ID: 21508173
[TBL] [Abstract][Full Text] [Related]
2. The catalytic A1 domains of cholera toxin and heat-labile enterotoxin are potent DNA adjuvants that evoke mixed Th1/Th17 cellular immune responses.
Bagley K; Xu R; Ota-Setlik A; Egan M; Schwartz J; Fouts T
Hum Vaccin Immunother; 2015; 11(9):2228-40. PubMed ID: 26042527
[TBL] [Abstract][Full Text] [Related]
3. SIV antigen-specific effects on immune responses induced by vaccination with DNA electroporation and plasmid IL-12.
Lindsay RW; Ouellette I; Arendt HE; Martinez J; DeStefano J; Lopez M; Pavlakis GN; Chiuchiolo MJ; Parks CL; King CR
Vaccine; 2013 Oct; 31(42):4749-58. PubMed ID: 23954384
[TBL] [Abstract][Full Text] [Related]
4. Gag and env conserved element CE DNA vaccines elicit broad cytotoxic T cell responses targeting subdominant epitopes of HIV and SIV Able to recognize virus-infected cells in macaques.
Hu X; Lu Z; Valentin A; Rosati M; Broderick KE; Sardesai NY; Marx PA; Mullins JI; Pavlakis GN; Felber BK
Hum Vaccin Immunother; 2018; 14(9):2163-2177. PubMed ID: 29939820
[TBL] [Abstract][Full Text] [Related]
5. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
[TBL] [Abstract][Full Text] [Related]
6. Protection by SIV VLP DNA prime/protein boost following mucosal SIV challenge is markedly enhanced by IL-12/GM-CSF co-administration.
O'Neill E; Martinez I; Villinger F; Rivera M; Gascot S; Colon C; Arana T; Sidhu M; Stout R; Montefiori DC; Martinez M; Ansari AA; Israel ZR; Kraiselburd E
J Med Primatol; 2002 Aug; 31(4-5):217-27. PubMed ID: 12390544
[TBL] [Abstract][Full Text] [Related]
7. GM-CSF DNA: an adjuvant for higher avidity IgG, rectal IgA, and increased protection against the acute phase of a SHIV-89.6P challenge by a DNA/MVA immunodeficiency virus vaccine.
Lai L; Vödrös D; Kozlowski PA; Montefiori DC; Wilson RL; Akerstrom VL; Chennareddi L; Yu T; Kannanganat S; Ofielu L; Villinger F; Wyatt LS; Moss B; Amara RR; Robinson HL
Virology; 2007 Dec; 369(1):153-67. PubMed ID: 17698160
[TBL] [Abstract][Full Text] [Related]
8. Virus-Like Particles Displaying Trimeric Simian Immunodeficiency Virus (SIV) Envelope gp160 Enhance the Breadth of DNA/Modified Vaccinia Virus Ankara SIV Vaccine-Induced Antibody Responses in Rhesus Macaques.
Iyer SS; Gangadhara S; Victor B; Shen X; Chen X; Nabi R; Kasturi SP; Sabula MJ; Labranche CC; Reddy PB; Tomaras GD; Montefiori DC; Moss B; Spearman P; Pulendran B; Kozlowski PA; Amara RR
J Virol; 2016 Oct; 90(19):8842-54. PubMed ID: 27466414
[TBL] [Abstract][Full Text] [Related]
9. CTA1-DD adjuvant promotes strong immunity against human immunodeficiency virus type 1 envelope glycoproteins following mucosal immunization.
Sundling C; Schön K; Mörner A; Forsell MNE; Wyatt RT; Thorstensson R; Hedestam GBK; Lycke NY
J Gen Virol; 2008 Dec; 89(Pt 12):2954-2964. PubMed ID: 19008380
[TBL] [Abstract][Full Text] [Related]
10. Vaccination of Macaques with DNA Followed by Adenoviral Vectors Encoding Simian Immunodeficiency Virus (SIV) Gag Alone Delays Infection by Repeated Mucosal Challenge with SIV.
Almond N; Berry N; Stebbings R; Preston M; Ham C; Page M; Ferguson D; Rose N; Li B; Mee ET; Hassall M; Stahl-Hennig C; Athanasopoulos T; Papagatsias T; Herath S; Benlahrech A; Dickson G; Meiser A; Patterson S
J Virol; 2019 Nov; 93(21):. PubMed ID: 31413132
[TBL] [Abstract][Full Text] [Related]
11. Viral vectored granulocyte-macrophage colony stimulating factor inhibits vaccine protection in an SIV challenge model: protection correlates with neutralizing antibody.
Schell JB; Bahl K; Rose NF; Buonocore L; Hunter M; Marx PA; LaBranche CC; Montefiori DC; Rose JK
Vaccine; 2012 Jun; 30(28):4233-9. PubMed ID: 22537983
[TBL] [Abstract][Full Text] [Related]
12. Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF.
Barouch DH; Santra S; Tenner-Racz K; Racz P; Kuroda MJ; Schmitz JE; Jackson SS; Lifton MA; Freed DC; Perry HC; Davies ME; Shiver JW; Letvin NL
J Immunol; 2002 Jan; 168(2):562-8. PubMed ID: 11777947
[TBL] [Abstract][Full Text] [Related]
13. IL-12/GM-CSF coadministration in an SIV DNA prime/protein boost protocol enhances Gag-specific T cells but not virus-specific neutralizing antibodies in rhesus macaques.
O'Neill E; Bostik V; Montefiori DC; Kraiselburd E; Villinger F
AIDS Res Hum Retroviruses; 2003 Oct; 19(10):883-90. PubMed ID: 14585220
[TBL] [Abstract][Full Text] [Related]
14. DNA prime/protein boost vaccination elicits robust humoral response in rhesus macaques using oligomeric simian immunodeficiency virus envelope and Advax delta inulin adjuvant.
Menon V; Ayala VI; Rangaswamy SP; Kalisz I; Whitney S; Galmin L; Ashraf A; LaBranche C; Montefiori D; Petrovsky N; Kalyanaraman VS; Pal R
J Gen Virol; 2017 Aug; 98(8):2143-2155. PubMed ID: 28758637
[TBL] [Abstract][Full Text] [Related]
15. Long-term control of simian immunodeficiency virus mac251 viremia to undetectable levels in half of infected female rhesus macaques nasally vaccinated with simian immunodeficiency virus DNA/recombinant modified vaccinia virus Ankara.
Manrique M; Kozlowski PA; Cobo-Molinos A; Wang SW; Wilson RL; Montefiori DC; Mansfield KG; Carville A; Aldovini A
J Immunol; 2011 Mar; 186(6):3581-93. PubMed ID: 21317390
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte-macrophage colony-stimulating factor, a potent adjuvant for polarization to Th-17 pattern: an experience on HIV-1 vaccine model.
Mahdavi M; Tajik AH; Ebtekar M; Rahimi R; Adibzadeh MM; Moozarmpour HR; Beikverdi MS; Olfat S; Hassan ZM; Choopani M; Kameli M; Hartoonian C
APMIS; 2017 Jun; 125(6):596-603. PubMed ID: 28493367
[TBL] [Abstract][Full Text] [Related]
17. A noninfectious simian/human immunodeficiency virus DNA vaccine that protects macaques against AIDS.
Singh DK; Liu Z; Sheffer D; Mackay GA; Smith M; Dhillon S; Hegde R; Jia F; Adany I; Narayan O
J Virol; 2005 Mar; 79(6):3419-28. PubMed ID: 15731236
[TBL] [Abstract][Full Text] [Related]
18. DNA prime Listeria boost induces a cellular immune response to SIV antigens in the rhesus macaque model that is capable of limited suppression of SIV239 viral replication.
Boyer JD; Robinson TM; Maciag PC; Peng X; Johnson RS; Pavlakis G; Lewis MG; Shen A; Siliciano R; Brown CR; Weiner DB; Paterson Y
Virology; 2005 Mar; 333(1):88-101. PubMed ID: 15708595
[TBL] [Abstract][Full Text] [Related]
19. Enhanced control of pathogenic Simian immunodeficiency virus SIVmac239 replication in macaques immunized with an interleukin-12 plasmid and a DNA prime-viral vector boost vaccine regimen.
Winstone N; Wilson AJ; Morrow G; Boggiano C; Chiuchiolo MJ; Lopez M; Kemelman M; Ginsberg AA; Mullen K; Coleman JW; Wu CD; Narpala S; Ouellette I; Dean HJ; Lin F; Sardesai NY; Cassamasa H; McBride D; Felber BK; Pavlakis GN; Schultz A; Hudgens MG; King CR; Zamb TJ; Parks CL; McDermott AB
J Virol; 2011 Sep; 85(18):9578-87. PubMed ID: 21734035
[TBL] [Abstract][Full Text] [Related]
20. Induction of HIV immunity in the genital tract after intranasal delivery of a MVA vector: enhanced immunogenicity after DNA prime-modified vaccinia virus Ankara boost immunization schedule.
Gherardi MM; Pérez-Jiménez E; Nájera JL; Esteban M
J Immunol; 2004 May; 172(10):6209-20. PubMed ID: 15128809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
